high dose PRT042 nasal spray

Phase 2Small molecule

SSichuan Purity Pharmaceutical Technology Co., Ltd.

high dose PRT042 nasal spray is one of 13 small molecule programs targeting Suicidal Ideation. It is currently in Phase 2.

Indications

Total Trials

Active Trials

Competitors

Pipeline

Status by Indication[3][1]

Indication

Suicidal IdeationActive, not recruiting

Suicidal IdeationPhase 2

Active, not recruiting

Competition

Competitive Landscape

19 competitors in Suicidal Ideation

#DrugCompanyPhaseTrials

Ketalar

AAultman Health Foundation

Approved

13 2

Minipress

Pfizer

Approved

1 3

Versed

CConrado Roberto Hoffmann Filho

Approved

2 4

Ketalar

Boehringer Ingelheim

Phase 3

6 5

Intranasal Ketamine

JJavelin Pharmaceuticals

Phase 3

1 6

Uridine

UUniversity of Utah

Approved

1 7

Zolpidem CR

MMassachusetts General Hospital

Approved

1 8

Cesamet

BBausch Health Americas, Inc.

Phase 2

1 9

Lurasidone HC1

Sumitomo Pharma America, Inc.

Phase 3

2 10

Psilocybin

COMPASS Pathways

Phase 2

Ranked by pipeline maturity and clinical activity. Current drug highlighted in teal.

Clinical

Trials by Indication[1]

Suicidal Ideation1 trial

A Study to Evaluate the Efficacy, Safety, and Pharmacokinetic Characteristics of (R)-Ketamine Hydrochloride Nasal Spray in Patients With Depression and Acute Suicidal Ideation or Behavior

Recruiting·SSichuan Purity Pharmaceutical Technology Co., Ltd.·Phase 2·NCT07193901·98 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for high dose PRT042 nasal spray. U.S. National Library of Medicine, National Institutes of Health.
[2]
ChEMBL — high dose PRT042 nasal spray compound record. European Bioinformatics Institute (EMBL-EBI).
[3]
Open Targets Platform — Drug–disease associations for high dose PRT042 nasal spray. EMBL-EBI & Wellcome Sanger Institute.
[4]
SEC EDGAR — Sichuan Purity Pharmaceutical Technology Co., Ltd. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Modality: Small molecule[2]
Highest Phase: Phase 2[1]
Company: SSichuan Purity Pharmaceutical Technology Co., Ltd.

high dose PRT042 nasal spray

Status by Indication[3][1]

Competitive Landscape

Trials by Indication[1]

Suicidal Ideation1 trial

References

Drug Info

Quick Facts

Related News